BioSpace News Archive

Evogene Provides 2020 Year-End Update for CRISPR-IL Consortium

Progress includes completion of a first version of the artificial intelligence-driven platform for genome-editing

January 5, 2021
·
7 min read
Pharm Country

Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines

Aro Biotherapeutics, a biotechnology company pioneering the development of tissue-targeted genetic medicines, today announced the closing of an $88 million Series A financing.

January 5, 2021
·
2 min read
Policy

Genentech’s Novel Anti-TIGIT Tiragolumab Granted FDA Breakthrough Therapy Designation in Combination With Tecentriq for PD-L1-High Non-Small Cell Lung Cancer

Tiragolumab is the first anti-TIGIT therapy to be granted Breakthrough Therapy Designation (BTD) and marks the 37th BTD for Genentech’s portfolio of medicines

January 5, 2021
·
14 min read
Polyphor to Take Part in Panel Discussion on Novel Oncology Targets at the LifeSci Partners 10th Annual Healthcare Corporate Access Event

Polyphor AG announced that Gökhan Batur, Chief Executive Officer, will take part in a panel discussion at the LifeSci Partners 10th Annual Healthcare Corporate Access Event on Thursday, January 7 from 8:00AM Eastern Standard Time.

January 5, 2021
·
2 min read
Business

ViGeneron signs global collaboration agreement for ophthalmic gene therapy development

Collaboration with Biogen to develop gene therapy for an undisclosed target to treat inherited eye disease, plus option for additional target

January 5, 2021
·
2 min read
Bio NC

Verona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference - Jan 05, 2021

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Chief Executive Officer and President, will present a company overview at the H.C. Wainwright Virtual BioConnect Conference.

January 5, 2021
·
2 min read
Terumo Enters 100th Anniversary Year

Terumo Corporation is celebrating its 100th anniversary this year - marking 100 years of ‘Contributing to Society through Healthcare’ on September 17, 2021.

January 5, 2021
·
2 min read
Genetown

Sosei Heptares to Regain Worldwide Rights to Muscarinic Agonist Programs

Sosei Group Corporation announces it is to regain the worldwide rights to its muscarinic agonist programs.

January 5, 2021
·
6 min read
Deals

Takeda Completes Sale of Select Non-Core Assets to Cheplapharm

Takeda Pharmaceutical Company Limited announced the completion of its previously-announced sale of a portfolio of select prescription products to Cheplapharm for a total value of $562 million USD.

January 5, 2021
·
7 min read
Biotech Beach

Bay Materials Obtains Patents to Protect Innovative Clear-Aligner Material Zendura™ FLX

Bay Materials LLC, a leader in high-performance thermoformable plastic materials for orthodontic clear aligner therapy, announced that the U.S. Patent and Trademark office has allowed and issued its second patent for Bay’s “Dual Shell Dental Appliance and Material Constructions” family of patents.

January 5, 2021
·
3 min read